PF-06263507

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-06263507, covering 2016-06-24 to 2016-06-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study Of PF-06263507 In Patients With Advanced Solid Tumors [Phase 1]